Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

BACKGROUND: With the increasing use of immune checkpoint inhibitors (ICIs) for tumour immunotherapy, the immune-related adverse events (irAEs) caused by their collateral effect on the immune system pose a key challenge for the clinical application of ICIs. Psychiatric adverse events are a class of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chaozheng, Peng, Shengkun, Lin, Anqi, Jiang, Aimin, Peng, Yuanxi, Gu, Tianqi, Liu, Zaoqu, Cheng, Quan, Zhang, Jian, Luo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149185/
https://www.ncbi.nlm.nih.gov/pubmed/37131541
http://dx.doi.org/10.1016/j.eclinm.2023.101967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149185/
https://www.ncbi.nlm.nih.gov/pubmed/37131541
http://dx.doi.org/10.1016/j.eclinm.2023.101967

Ejemplares similares